184 search results
- Current search:
- Colorectal Cancer
- Reset
Primary tabs
- Cochrane Evidence (active tab)
- Resources
- Handbooks & Manuals
- Training & Workshops
- News
- All Cochrane sites
-
Cochrane EvidencePublished 27 Jun 2017
Epidermal growth factor receptor (EGFR) inhibitors for metastatic colorectal cancer
Background Cancer of the colon or rectum that has spread to other organs (metastatic colorectal cancer) is a commonly occurring disease that usually cannot be surgically removed. The main treatment is chemotherapy, targeted therapy (such as EGFR inhibitors, the subject of this review), or both. The epidermal growth factor receptor (EGFR) is a protein ... -
Cochrane EvidencePublished 21 Jun 2017
Different gases for insufflation of the abdominal cavity during key-hole abdominal surgery
Review question What are the benefits and harms of various gases for insufflation (inflation with gas) of the abdominal (tummy) cavity to allow easier access to organs during laparoscopic (key-hole) abdominal surgery? Background Laparoscopic (key hole) surgery is now widely performed to treat various abdominal diseases. An ideal gas for insufflation ... -
NewCochrane EvidencePublished 2 Jun 2017
Early or delayed surgical removal of appendix in people with symptomatic complicated appendicitis
Review question What are the risks and benefits of early versus delayed removal of appendix in people with symptomatic complicated appendicitis? Background The human appendix is a tube at the connection of the small and the large intestines. Possible functions of the appendix may be to protect the body against infection and to maintain healthy levels ... -
NewCochrane EvidencePublished 1 Jun 2017
Management of intussusception in children
Review question How is intussusception best managed in children? Background Intussusception is a medical emergency that occurs in children when a part of the bowel 'telescopes' (folds) into another part of the bowel. This causes pain, vomiting, and obstruction, preventing passage. If left untreated, the bowel can perforate, resulting in passage ... -
Cochrane EvidencePublished 7 Feb 2017
Glue may be a sensible alternative to suture for mesh fixation in Lichtenstein inguinal hernioplasty
Review question We reviewed whether glue can reduce chronic pain after surgery, without increasing the postoperative recurrence rate, compared with sutures for mesh fixation in Lichtenstein inguinal hernia repair. Background A hernia is a weakness of the abdominal wall and allows escape of soft tissue or internal organs. It usually appears as a ... -
Cochrane EvidencePublished 27 Jan 2017
Second-line therapy can increase survival of people with metastatic colorectal cancer who did not respond to a first treatment
Review question We reviewed the ability of chemotherapy drugs (medicines used to treat cancer) to reduce tumour size and improve survival in people with metastatic colorectal cancer who had not responded to a prior treatment. We also looked at the side effects caused by the different drug regimens. Background People with metastatic colorectal cancer ... -
Cochrane EvidencePublished 8 Jan 2017
Does dietary fibre prevent the recurrence of colorectal adenomas and carcinomas?
We asked Does nutritional supplement of dietary fibre prevent recurrence of precancerous polyps and cancer in the bowel in participants with a history of polyps having been removed to achieve a polyp-free colon at baseline for the intervention. Background Colorectal (bowel) cancer is common worldwide but is especially prevalent in industrialised ... -
Cochrane EvidencePublished 21 Dec 2016
Intermittent versus continuous systemic therapy as treatment for unresectable metastatic colorectal cancer
Protocol: To assess the effect of intermittent systemic therapy versus continuous systemic therapy in terms of survival, toxicity and quality of life in patients with unresectable metastatic colorectal cancer (CRC). -
Cochrane EvidencePublished 7 Dec 2016
Adjuvant anti-VEGF therapy for overall survival and relapse-free survival in patients with resected non-metastatic colorectal cancer
Protocol: To assess the efficacy and safety of the use of anti-angiogenic agents (VEGF inhibitors) in the adjuvant setting after resection in patients diagnosed with resectable colorectal cancer.This would permit a summary of the safety and effectiveness of anti-VEGF therapies overall, as well as in pre-planned prognostic subgroups, and identify ... -
Cochrane EvidencePublished 24 Nov 2016
Follow-up strategies for participants treated for non-metastatic colorectal cancer
What is the issue? Colorectal cancer affects about 1 in 20 people in developed countries. Most patients (about two thirds) have curable disease. Follow-up after curative treatment usually means visits to the doctor as well as having some tests. Many people believe that follow-up saves lives, but we are not sure how often the patient should see the ...
